iTeos Therapeutics Inc.

NASDAQ: ITOS · Real-Time Price · USD
10.11
0.00 (0.00%)
At close: Aug 15, 2025, 3:59 PM
10.11
0.05%
After-hours: Aug 15, 2025, 05:36 PM EDT

iTeos Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
142.13M 251.18M 284.8M 848.54M
Short-Term Investments
352.52M 280.74M 328.36M n/a
Long-Term Investments
160.35M 100.54M 118.22M 298K
Other Long-Term Assets
7.1M 5.67M 1.7M 2.3M
Receivables
3.69M 6.5M 2.44M 12.09M
Inventory
n/a n/a n/a n/a
Other Current Assets
11.2M 12.24M 12.7M n/a
Total Current Assets
509.54M 550.65M 628.3M 874.71M
Property-Plant & Equipment
9.98M 10.73M 6.77M 7.4M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
177.44M 116.94M 126.69M 10M
Total Assets
686.98M 667.59M 754.99M 884.71M
Account Payables
8.5M 11.29M 7.66M 5.14M
Deferred Revenue
1.4M 2.06M 13.78M 281.05M
Short-Term Debt
1.34M n/a 836K 770K
Other Current Liabilities
29.12M 16.84M -836K -770K
Total Current Liabilities
40.36M 40.01M 42M 304.12M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
52.56M 47.54M 45.82M 23.2M
Total Long-Term Liabilities
56.32M 52.35M 49.66M 27.77M
Total Liabilities
96.68M 92.36M 91.66M 331.89M
Total Debt
5.1M 6.06M 4.67M 5.34M
Common Stock
37K 36K 36K 35K
Retained Earnings
-9.78M 124.63M 237.28M 140.62M
Comprehensive Income
-16M -13.24M -9.64M -1.02M
Shareholders Equity
590.29M 575.23M 663.33M 552.82M
Total Investments
512.87M 381.28M 446.58M 298K